• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26920
Device Problem Entrapment of Device (1212)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/24/2020
Event Type  malfunction  
Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event Description
It was reported that guidewire entrapment occurred.The target lesion was located in the distal superficial femoral artery (sfa)/proximal popliteal artery.A 5x150x130 innova self expanding stent was deployed with no issues.After stent deployment, the delivery catheter was unable to be removed from the patient over the guidewire.The delivery system started to come back; however stopped just proximal to where the stent was deployed.A buddy wire was placed to maintain access and the stent and guidewire were removed together.After removal, the stent was unable to be removed from the guidewire outside the patient.The procedure was completed with a different guidewire.An innova 5.0x150x130, innova 5.0x120x130 and an epic 7.0x40x75 were deployed without incident.There were no patient complications reported.
 
Manufacturer Narrative
A2: age at time of event: 18 years or older.Device evaluated by mfr: returned product consisted of an innova self-expanding stent system with a 0.035 inch guidewire stuck inside it.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed a kink to the nosecone.Microscopic examination revealed no additional damages.The handle was opened and no additional damages were found.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Event Description
It was reported that guidewire entrapment occurred.The target lesion was located in the distal superficial femoral artery (sfa)/proximal popliteal artery.A 5x150x130 innova self expanding stent was deployed with no issues.After stent deployment, the delivery catheter was unable to be removed from the patient over the guidewire.The delivery system started to come back; however stopped just proximal to where the stent was deployed.A buddy wire was placed to maintain access and the stent and guidewire were removed together.After removal, the stent was unable to be removed from the guidewire outside the patient.The procedure was completed with a different guidewire.An innova 5.0x150x130, innova 5.0x120x130 and an epic 7.0x40x75 were deployed without incident.There were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9958669
MDR Text Key187703739
Report Number2134265-2020-04998
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/07/2022
Device Model Number26920
Device Catalogue Number26920
Device Lot Number0024066053
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/14/2020
Initial Date Manufacturer Received 03/24/2020
Initial Date FDA Received04/14/2020
Supplement Dates Manufacturer Received04/28/2020
Supplement Dates FDA Received05/19/2020
Patient Sequence Number1
Treatment
GUIDEWIRE: COOK AMPLATZ STIFF WIRE; GUIDEWIRE: COOK AMPLATZ STIFF WIRE
-
-